Idience Co., Ltd.
PrivateLast Round
Strategic
May 20, 2024
Total Funding Raised
$66M
Company Overview
Idience Co., Ltd. is a biopharmaceutical company that develops targeted oncology therapies, including its lead PARP inhibitor candidate, Venadaparib.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Idience Co., Ltd. Comparables
Compare Idience Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duke Street Bio | 87% | |
| Onconic Therapeutics | 81% | |
| Synnovation Therapeutics | 81% | |
Idience Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 20, 2024 | ||||
| Series B | Jul 1, 2022 | ||||
| Series A | Nov 9, 2020 |
Idience Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series B, Series A |
| KIWOOM Securities Co., Ltd. | Series B |
| TS Investment | Series A |
| Ildong Holdings Co., Ltd. | Series B |
| Mirae Asset Capital | Series A |
| Yuanta Investment | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2024
Monthly visitors increased 84% MoM, reaching 1.8K.
- Nov 9, 2020
$36M round with Mirae Asset Capital and Seoul Investment Partners.
Idience Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Idience Co., Ltd.'s valuation, stock price, and market status.